GlobalData on MSN

Pfizer and Novavax ink $530m vaccine delivery licensing deal

Pfizer will now employ Novavax’s adjuvant, Matrix-M, into its vaccines across two disease areas.

Here's Why Pfizer Is Willing To Pay $500 Million For Novavax's Matrix-M

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
WKBW

Novavax vaccine may be option for troops with religious concerns

A COVID-19 vaccine that could soon win federal authorization may offer a boost for the U.S. military: an opportunity to get shots into some of the thousands of service members who have refused the ...